Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "WSJ’s Daniela Hernandez"


23 mentions found


Earlier: Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over unintended consequences. Illustration: Elizabeth SmelovU.S. drug regulators have approved expanding the use of Eli Lilly ’s diabetes drug Mounjaro to include the treatment of obesity. The Food and Drug Administration’s decision Wednesday furthers the rapid rise of Mounjaro—and similar-acting therapies Ozempic and Wegovy from Novo Nordisk —that have in a matter of months reshaped the treatment of obesity and doctors’ understanding of its roots.
Persons: WSJ’s Daniela Hernandez, Elizabeth Smelov, Eli Lilly ’, Ozempic Organizations: Novo Nordisk Locations: Elizabeth Smelov U.S, Novo
Obesity Drug Demand Outstrips Supply
  + stars: | 2023-11-02 | by ( David Wainer | ) www.wsj.com   time to read: 1 min
Diabetes drugs could become an effective way to treat behavioral issues and addiction. WSJ’s Daniela Hernandez breaks down the science on how they work and how they could change psychiatry forever. Photo illustration: Elizabeth SmelovEli Lilly ’s blockbuster diabetes medication Mounjaro is expected to receive Food and Drug Administration approval as an obesity treatment before the end of the year, which would lead to a surge in demand. Whether there will be enough of the drug is a different question. Both Lilly and its competitor, Denmark’s Novo Nordisk , which makes Ozempic and its sister drug Wegovy, are struggling to meet skyrocketing demand for their medications.
Persons: WSJ’s Daniela Hernandez, Elizabeth Smelov Eli Lilly ’, Mounjaro, Lilly Organizations: Drug Administration, Denmark’s, Denmark’s Novo Nordisk Locations: Denmark’s Novo
Diabetes drugs could become an effective way to treat behavioral issues and addiction. WSJ’s Daniela Hernandez breaks down the science on how they work and how they could change psychiatry forever. Photo illustration: Elizabeth SmelovWegovy maker Novo Nordisk reported soaring profit, boosted by blockbuster weight-loss drugs that have quickly made the Danish drugmaker Europe’s most valuable company. Surging demand for the drugs has supercharged the company’s stock price, tilted the scales of its home economy in Denmark and triggered a frenzy on Wall Street over how the treatments and others like it might affect other industries, including snack foods and airlines.
Persons: WSJ’s Daniela Hernandez, Elizabeth Smelov Organizations: Novo Nordisk Locations: Danish, Denmark
Why Grass Is a Culprit in Some of the World’s Worst Wildfires The spread of invasive grasses in places like Hawaii and the Western U.S. is contributing to more frequent wildfires. WSJ’s Daniela Hernandez explains why and explores what's being done to curb their spread. Photo illustration: David Fang
Persons: Daniela Hernandez, David Fang Locations: Hawaii, Western U.S
Ozempic Boom Is an Opportunity for Health Insurers
  + stars: | 2023-10-20 | by ( David Wainer | ) www.wsj.com   time to read: 1 min
WSJ’s Daniela Hernandez breaks down the science of how diabetes drugs work—and how they could change psychiatry. Photo illustration: Elizabeth SmelovYou would think a new class of high-price weight loss drugs taken by millions of Americans would be a problem for health insurers. But it is more complicated than that: Some insurance giants actually stand to profit from the Ozempic craze. The industry has been calling out the costs of GLP-1 drugs, which are used for both diabetes and obesity. But federally supported Medicare and Medicaid still don’t cover the drugs for obesity, and much of the commercial market is self-insured.
Persons: WSJ’s Daniela Hernandez, Elizabeth Smelov, Aetna
The Brain Science of Aggression and Why Lashing Out Can Feel Good Nearly one in four people surveyed in Gallup's latest Global Emotions Report said they’d recently felt anger. WSJ’s Daniela Hernandez explains the neuroscience behind rage, the roles it plays in our lives and how we can keep it in check. Photo composite: David Fang
Persons: they’d, WSJ’s Daniela Hernandez, David Fang
The Brain Science of Aggression and Why Lashing Out Can Feel Good Nearly one in four people surveyed in Gallup's latest Global Emotions Report said they’d recently felt anger. WSJ’s Daniela Hernandez explains the neuroscience behind rage, the roles it plays in our lives and how we can keep it in check. Photo composite: David Fang
Persons: they’d, WSJ’s Daniela Hernandez, David Fang
The Brain Science of Aggression and Why Lashing Out Can Feel Good Nearly one in four people surveyed in Gallup's latest Global Emotions Report said they’d recently felt anger. WSJ’s Daniela Hernandez explains the neuroscience behind rage, the roles it plays in our lives and how we can keep it in check. Photo composite: David Fang
Persons: they’d, WSJ’s Daniela Hernandez, David Fang
The Brain Science of Aggression and Why Lashing Out Can Feel Good Nearly one in four people surveyed in Gallup's latest Global Emotions Report said they’d recently felt anger. WSJ’s Daniela Hernandez explains the neuroscience behind rage, the roles it plays in our lives and how we can keep it in check. Photo composite: David Fang
Persons: they’d, WSJ’s Daniela Hernandez, David Fang
S1 E43The Brain Science of Aggression and Why Lashing Out Can Feel Good Nearly one in four people surveyed in Gallup's latest Global Emotions Report said they’d recently felt anger. WSJ’s Daniela Hernandez explains the neuroscience behind rage, the roles it plays in our lives and how we can keep it in check. Photo composite: David Fang
Persons: they’d, WSJ’s Daniela Hernandez, David Fang
The Brain Science of Aggression and Why Lashing Out Can Feel Good Sadness and anger are on the rise, here’s what scientists understand about itBy Daniela Hernandez Jun 23, 2023 11:00 am Nearly one in four people surveyed in Gallup's latest Global Emotions Report said they’d recently felt anger. WSJ’s Daniela Hernandez explains the neuroscience behind rage, the roles it plays in our lives and how we can keep it in check. Photo composite: David Fang
Persons: Daniela Hernandez Jun, they’d, WSJ’s Daniela Hernandez, David Fang
WSJ’s Daniela Hernandez explains how over-the-counter access could affect reproductive care across the U.S. Photo: Laura KammermannAs efforts to crack down on abortion increase around the U.S., contraceptives are bound to play an increasingly important role in family planning. But for many women, cost and access are still prohibitive factors. A cheaper, over-the-counter option could help close that gap while creating a sizable market for generic drugmaker Perrigo . Advisers to the Food and Drug Administration earlier this week recommended that Perrigo’s oral contraceptive, called Opill, be made available without prescription. If the recommendation is adopted by the FDA, it would help widen access to birth control around the country.
E37Why Fungi Are the Next Big Global Health Threat As certain fungi like Candida auris become more widespread throughout the U.S., deaths related to severe fungal infections are rising. WSJ’s Daniela Hernandez explains what you should know. Composite: Noah Friedman
Obesity Could Be Pharma’s Biggest Blockbuster Yet
  + stars: | 2023-05-05 | by ( David Wainer | ) www.wsj.com   time to read: 1 min
Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over unintended consequences. Illustration: Elizabeth SmelovAs social-media hype around drugs like Ozempic and Mounjaro explodes, patient testimonies have focused not only on the dramatic effect on their waistlines, but also on how quickly many seem to pack the pounds back on if they stop taking the injections. That may not be ideal for patients, but for Wall Street it is a feature rather than a bug. Nothing gets investors more hyped up than a product whose target market is massive—more than 40% of American adults are obese—and that also needs to be taken indefinitely.
Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over unintended consequences. Illustration: Elizabeth SmelovThe Danish pharmaceutical giant that makes the obesity drug Wegovy said it would temporarily hold back some lower-strength starter doses in the U.S. in an effort to safeguard supplies for current patients amid soaring demand. The Food and Drug Administration cleared Wegovy, made by Novo Nordisk , as a treatment for chronic weight management in 2021. It has since exploded in popularity.
E35The Science Behind Cold Plunges, Explained in Four Minutes Cold plunges and ice baths are all the rage, but does research actually back up claims that they have health benefits? WSJ’s Daniela Hernandez explains what’s known (and what’s not) about the science of cold exposure. Photo: Kerem Yucel/Agence France-Presse/Getty Images
Why Fungi Are the Next Big Global Health Threat
  + stars: | 2023-03-24 | by ( Daniela Hernandez | ) www.wsj.com   time to read: 1 min
E35The Science Behind Cold Plunges, Explained in Four Minutes Cold plunges and ice baths are all the rage, but does research actually back up claims that they have health benefits? WSJ’s Daniela Hernandez explains what’s known (and what’s not) about the science of cold exposure. Photo: Kerem Yucel/Agence France-Presse/Getty Images
E33What Science Tells Us About the Surge in Strep and Flu This Season Getting the flu can increase the risk of getting a second infection, including strep throat. WSJ’S Daniela Hernandez explains the science behind that, plus what it means for the rest of the winter and how we can protect ourselves from the tripledemic. Illustration: David Fang
E33What Science Tells Us About the Surge in Strep and Flu This Season Getting the flu can increase the risk of getting a second infection, including strep throat. WSJ’S Daniela Hernandez explains the science behind that, plus what it means for the rest of the winter and how we can protect ourselves from the tripledemic. Illustration: David Fang
E35What Science Tells Us About the Surge in Strep and Flu This Season Getting the flu can increase the risk of getting a second infection, including strep throat. WSJ’S Daniela Hernandez explains the science behind that, plus what it means for the rest of the winter and how we can protect ourselves from the tripledemic. Illustration: David Fang
E29Covid Variants Keep Getting More Infectious. Here’s Why. With each mutation, the Covid-19 virus is becoming more transmissible. WSJ’s Daniela Hernandez breaks down the science of how Covid variants are getting better at infecting and spreading. Illustration: Rami Abukalam
VideoResearchers Look to Fungi for the Future of Building MaterialsCould mushrooms be the answer to building sustainable homes and workspaces in the future? WSJ’s Daniela Hernandez explores how researchers and companies are looking to develop bricks out of fungi that rival traditional building materials. Illustration: Laura Kammermann
S1 E43The Brain Science of Aggression and Why Lashing Out Can Feel Good Nearly one in four people surveyed in Gallup's latest Global Emotions Report said they’d recently felt anger. WSJ’s Daniela Hernandez explains the neuroscience behind rage, the roles it plays in our lives and how we can keep it in check. Photo composite: David Fang
Persons: they’d, WSJ’s Daniela Hernandez, David Fang
Total: 23